The Recall Desk
SevereFDA (Drugs)·D-1869-2019·Announced 2019-09-25

Aurolife Recalls Fexofenadine Tablets Due to Impurity Failures

Aurolife Pharma is recalling equate Allergy Relief tablets because they failed impurity and degradation specifications.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class II, which corresponds to a Severe severity score under the rubric for drug recalls involving specification failures.

Plain-English summary

Aurolife Pharma, LLC is recalling equate Allergy Relief (Fexofenadine HCl) tablets USP, 180 mg, 15-count cartons. The recall involves 129,600 cartons distributed nationwide in the USA by Wal-Mart Stores, Inc.

The recall was initiated because the product failed impurities and degradation specifications. The affected lots are 067180010A (Exp 03/21), 067180023C1, and 067180024D1 (Exp 07/21). The NDC for the product is 49035-995-62.

Consumers who have purchased these specific lots should stop using the product and contact their pharmacist or the recalling firm for further instructions.

The recalled product

Product
Allergy Relief (Fexofenadine HCl) tablets USP, 180 mg, 15-count cartons, equate, Distributed by: Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-995-62.
Affected units
129,600

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (5)

  • Lot #s: 067180010A
  • Exp 03/21
  • 067180023C1
  • 067180024D1
  • Exp 07/21

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 11 recalled by Aurolife Pharma, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 11 products in this recall →